Quantitative electroencephalography of medetomidine, medetomidine-midazolam and medetomidine-midazolam-butorphanol in dogs

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 49, Issue 4, 2002, Pages 169-172

  Itamoto, K ^a   Taura, Y ^a   Wada, N ^a   Takuma, T ^a   Une, S ^a   Nakaichi, M ^a   Hikasa, Y ^a,b  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BUTORPHANOL; HYPNOTIC SEDATIVE AGENT; MEDETOMIDINE; MIDAZOLAM; NARCOTIC ANALGESIC AGENT;

ANESTHESIA; ANIMAL; ANIMAL DISEASE; ARTICLE; BRAIN; DOG; DOSE RESPONSE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; KINETICS; MALE; METHODOLOGY; PHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; ANALGESICS, OPIOID; ANESTHESIA; ANIMALS; BRAIN; BUTORPHANOL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAMUSCULAR; KINETICS; MALE; MEDETOMIDINE; MIDAZOLAM;

EID: 0036560040     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0442.2002.00425.x     Document Type: Article

References (34)

1. Bartram, D. H., M. J. Diamond, A. S. Tute, A. W. Trafford, and R. S. Jones, 1994: Use of medetomidine and butorphanol for sedation in dogs. J. Small Anim. Pract. 35, 495-498.
2. Billard, V., P. L. Gambus, N. Chamoun, D. R Stanski, and S. L. Shafer, 1997. A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect. Clin. Pharmacol. Ther. 61, 45-58.
3. Bol, C. J., J. P Vogelaar, J. P. Tang, and J. W. Mandema, 2000: Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat. J. Pharmacol. Exp Ther. 294, 347-355.
4. Bührer, M., P. O. Maitre, O. Hung, and D. R. Stanski. 1990: Electroencephalographic effects of benzodiazepines. I. Choosing an electroencephalographic parameter to measure the effect of midazolam on the central nervous system. Clin. Pharmacol. Ther. 40, 544-554.
5. Court, M. H., and D J. Greenblatt, 1992: Pharmacokinetics and preliminary observations of behavioural changes following administration of midazolam to dogs. J. Vet. Pharmacol. Ther. 15, 343-350.
6. Doze, V. A., B. X. Chen, Z. Li, R. G. Vickery, and M. Maze, 1988: Characterization of the alpha 2 adrenoceptor-effector mechanism for the hypnotic action of MPV-1440 in rats. Anesthesiology 69, A619.
7. Fleischer, J. E., J. H. Milde, T. P. Moyer, and J. D Michenfelder, 1988: Cerebral effects of high-dose midazolam and subsequent reversal with Ro 151788 in dogs Anesthesiology 67, 234-242.
8. Haefely, W. E., 1989: Pharmacology of the benzodiazepine receptor. Eur. Arch. Psychiatr. Neurol. Sci. 238, 294-301.
9. Hosgood, G., 1990: Pharmacologic features of butorphanol in dogs and cats. J. Am. Vet. Med. Assoc. 196, 135-136.
10. Ilkiw, J. E., C. M. Suter, T. B. Farver, D. McNeal, and E. P. Steffey, 1996: The behaviour of healthy awake cats following intravenous and intramuscular administration of midazolam. J. Vet. Pharmacol. Therap. 19, 205-216.
11. Itamoto, K., Y. Hikasa, I. Sakonjyu, H. Itoh, T. Kakuta, and K. Takase, 2000: Anaesthetic and cardiopulmonary effects of balanced anaesthesia with medetomidine-midazolam and butorphanol in dogs. J. Vet. Med. A. 47, 441-420.
12. Itamoto, K., Y Taura, N Wada, A. Taga. T Takuma, H. MatsumuraT., E E. G. Miyara, 2001. Effect of medetomidine on electroencephalography and use of a quantitative electroencephalograph for evaluating sedation levels in dogs J Vet. Med. A. 48, 525-535.
13. Kane, N. M., T. H. Moss, S. H. Curry, and S. R. Butler, 1998: Quantitative electroencephalographic evaluation of non-fatal and fatal traumatic coma. Electroenccphalogr. Clin. Neurophysiol. 106, 244-250.
14. Khanderia, U., and S.K Pandit, 1987: Use of midazolam hydrochloride in anesthesia. Clin. Pharm. 6, 533-547.
15. Ko, J. C., J. E. Bailey, L. S. Pablo, and T. G. Heaton-Jones, 1996: Comparison of sedative and cardiorespiratory effects of medetomidine and medetomidine-butorphanol combination in dogs. Am. J. Vet. Res. 57, 535-540.
16. Lammintausta, R., 1986: Introduction to adrenoceptor pharmacology Acta Vet. Scand. 82, 11-16.
17. Lemmens, H. J., T. D. Egan, P. Fiset, and D R. Stanski, 1995: Pharmacokinetic/dynamic assessment in drug development: application to the investigational opioid mirfentanil. Anesth Analg. 80, 1206-1211.
18. Liu, J., H. Singh, and P. F. White, 1996: Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation Anesthesiology 84, 64-69.
19. Lloyd-Thomas, A R , and P. V. Cole, 1990: Quantitative EEG and brainstem auditory evoked potentials: comparison of isoflurane with halothane using the cerebral function analysing monitor. Br. J. Anaesth. 65, 306-312.
20. Maze, M., 1989: Anesthesia and ion channel function in the autonomic nervous system. Int. Anesthesiol. Clin. 27, 248-258.
21. Ogawa, T., Y. Sano, Y. Hirabayashi, H. Yoshikawa, A. Waukuier, P. Cuesta, B. Clinken, M. William, and V. D. Broeck, 1987: Effect of agonistic morphine antagonists (cyclazocine, butorphanol, buprenorphine) on EEG activity and depth of anesthesia in rats. Masui 36, 490-497.
22. Ossipov, M. H., R. Lozito, E. Messineo, J. Green, S. Harris, and P. Lloyd, 1990: Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: isobolographic analysis. Life Sci. 47, PL71-PL76.
23. Pepper, C. M., and G. Henderson, 1980: Opiates and opioid peptides hyperpolarize locus coeruleus neurons in vitro. Science 209, 394-395.
24. Pypendop, B , and J. Verstegen, 1999: Cardiorespiratory effects of a combination of medetomidine, midazolam, and butorphanol in dogs. Am. J. Vet. Res. 60, 1148-1154.
25. Redding, R. W., R. B. Prynn, and J. L. Wagner, 1966: Clinical use of the electroencephalogram in canine encephalitis. J. Am. Vet. Med. Assoc. 148, 141-149.
26. Salonen, M., K. Reid. and M Maze, 1992: Synergistic interaction between alpha 2-adrenergic agonists and benzodiazepines in rats. Anesthesiology 76, 1004-1011.
27. Schneider, G., and P. S Sebel, 1997: Monitoring depth of anaesthesia. Eur. J. Anaesthesiol. 14, 21-28.
28. Schwender, D., M. Daunderer, S. Mulzer, S. Klasing, U. Finsterer, and K. Peter. 1996: Spectral edge frequency of the electroencephalogram to monitor 'depth' of anaesthesia with isoflurane or propofol. Br. J. Anaesth 77, 179-184.
29. Short, C. E., J E. Räihä, M P. Räihä, and K. Otto, 1992: Comparison of neurologic responses to the use of medetomidine as a sole agent or preanesthetic in laboratory beagles. Acta Vet. Scand. 33, 77-88.
30. Stanski, D. R., 1992: Pharmacodynamic modeling of anesthetic EEG drug. Annu. Rev. Pharmacol. Toxicol. 32, 423-447.
31. Thomsen, C. E., and P. F. Prior, 1996: Quantitative EEG in assessment of anaesthetic depth: comparative study of methodology. Br. J Anaesth. 77, 172-178.
32. Travagli, R. A., T. V. Dunwiddie, and J. T. Williams, 1995: Opioid inhibition in locus coeruleus. J. Neurophysiol. 74, 518-528.
33. Vähä-Vahe, T., 1989: The clinical efficacy of medetomidine. Acta Vet. Scand. 85, 151-153.
34. Vainio, O., T. Vähä-Vahe, and L. Palmu, 1989: Sedative and analgesic effects of medetomidine in dogs. J. Vet. Pharmacol. Ther. 12, 225-231.